Serial Number | 98175319 |
Word Mark | DWELL |
Filing Date | Tuesday, September 12, 2023 |
Status | 601 - ABANDONED - EXPRESS |
Status Date | Tuesday, May 28, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Incubation services, namely, rental of office space to freelancers, start-ups, existing businesses and non-profits; Real estate services, namely, rental, brokerage, leasing and management of commercial property, offices and office space; Rental of office space; Rental of offices for co-working |
International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Monday, January 29, 2024 |
Primary Code | 036 |
First Use Anywhere Date | Sunday, July 24, 2022 |
First Use In Commerce Date | Tuesday, November 15, 2022 |
Party Name | Dwell Coworking, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Pflugerville, TX 78660 |
Event Date | Event Description |
Tuesday, September 12, 2023 | NEW APPLICATION ENTERED |
Sunday, November 26, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, January 29, 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Monday, January 29, 2024 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
Wednesday, February 21, 2024 | LETTER OF PROTEST EVIDENCE FORWARDED |
Tuesday, May 7, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, May 7, 2024 | ASSIGNED TO EXAMINER |
Tuesday, May 7, 2024 | LETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN |
Tuesday, May 7, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, May 7, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, May 23, 2024 | TEAS EXPRESS ABANDONMENT RECEIVED |
Tuesday, May 28, 2024 | ABANDONMENT - EXPRESS MAILED |
Tuesday, May 28, 2024 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT |